Gamida Cell took over commercialization of Aphexda, leading a partnership to advance studies in PDAC. Data was presented at the ASCO meeting on August 15, 2025.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Gamida Cell took over commercialization of Aphexda, leading a partnership to advance studies in PDAC. Data was presented at the ASCO meeting on August 15, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Gamida Cell (Israel)
company in Jerusalem, Israel
Nothing else this week.
-
Biokine (Israel)
company in Rehovot, Israel
Nothing else this week.
-
Gloria
Bulgarian pop-folk singer
Nothing else this week.
Coverage
Newest first; wire copies grouped- Zacks Small Cap ResearchBLRX: ASCO Poster & Abstract By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ:BLRX) reported second quarter 2025 results, producing license revenues of